Clinical and economic evaluation of diagnostic tests in wound care

“这项研究旨在确定使用Woundchek的细菌状态和升高的蛋白酶状态测试来指导诊断为慢性的伤口治疗是否对患者和NHS有益。检测升高的蛋白酶和细菌蛋白酶，然后进行适当的管理，可以改善患者的健康和生活质量，以及资源的使用，避免不必要的治疗，如减少护理时间，减少患者的门诊次数和缩短总治疗时间。市场上没有针对这些条件的其他测试，也没有进行其他比较研究。NHS的伤口护理成本每年约为50亿英镑（并且还在不断增长），与肥胖症的成本相当。"

"* This study aims to determine whether the use of Woundchek's Bacterial Status and Elevated Protease Status tests to guide treatment of wounds diagnosed as chronic is beneficial to the patient and to the NHS.* Testing for elevated protease and bacterial protease and then managing appropriately could improve the health and quality of life of patients, as well as the use of resources as avoidance of unnecessary treatments such as less nursing time, fewer clinic visits for the patient and shorter overall treatment duration. There are no other tests for these conditions on the market and no other comparative studies have been conducted.* The cost of wound care to the NHS is around £5billion per annum (and growing), comparable to the cost of obesity."